WASHINGTON (AP) — The Supreme Court seems likely to side with drugmaker Merck in a dispute over the warning label on its bone-strengthening drug Fosamax. During arguments Monday in a lawsuit against the New Jersey-based company, only two justices seemed inclined to rule against Merck. A trial court initially threw out claims against Merck. An […]
